Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM6B | O15054 | 1/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.43 |
| ▸ | GABRP | O00591 | 5/20 | 0.41 |
| ▸ | GABRD | O14764 | 5/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 5/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4717959 | 0.98 | NAPRT (0.47) | NAPRTKDM4EKMT2AMEN1ALDH1A1 | |
| SCHEMBL3663171 | 0.83 | SIRT3 (0.42) | NAPRTKMT2AMEN1TDP1CYP1A2 | |
| SCHEMBL31139857 | 0.81 | NTRK1 (0.39) | NAPRTKMT2AMEN1TDP1HCAR2 | |
| SCHEMBL23094464 | 0.81 | NTRK1 (0.39) | NAPRTKMT2AMEN1TDP1HCAR2 | |
| SCHEMBL68960 | 0.80 | KDM4E (0.47) | NAPRTKDM4EKMT2AMEN1ALDH1A1 | |
| SCHEMBL30858777 | 0.78 | P2RX7 (0.46) | KDM4EALDH1A1MAPTCYP1A2CYP3A4 | |
| SCHEMBL3046078 | 0.76 | KDM4E (0.50) | KDM4EALDH1A1MAPTL3MBTL1LMNA | |
| SCHEMBL1230875 | 0.76 | NTRK1 (0.44) | NTRK1PIK3CDIKBKETBK1 | |
| SCHEMBL2575802 | 0.76 | HCAR2 (0.44) | NAPRTKDM4EKMT2AMEN1ALDH1A1 | |
| SCHEMBL9632777 | 0.75 | HCAR2 (0.40) | NAPRTKDM4EKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119552597-A | Preparation method of high-performance composite binder for graphite negative electrode | 江阴纳力新材料科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-113200924-B | 4-amino-5-pyrimidine formamide compound and preparation method and application thereof | 南开大学 | 2022-11-01 | — | — | CN | claimed |
| CN-113200924-A | 4-amino-5-pyrimidine formamide compound and preparation method and application thereof | 南开大学 | 2021-08-03 | — | — | CN | claimed |
| US-7678818-B2 | Anthranilamide and 2-amino-heteroarene-carboxamide compounds | HOFFMANN-LA ROCHE INC. (US) | 2010-03-16 | — | — | US | claimed |
| JP-5112559-A | — | — | None | — | — | JP | disclosed |
| JP-9077766-A | — | — | None | — | — | JP | disclosed |
| CN-119552597-A | Preparation method of high-performance composite binder for graphite negative electrode | 江阴纳力新材料科技有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024255845-A1 | PROTEIN DEGRADATION AGENT, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 中国科学院上海药物研究所 | 2024-12-19 | — | — | WO | disclosed |
| CN-119143748-A | Protein degradation agent, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2024-12-17 | — | — | CN | disclosed |
| US-11702401-B2 | Compounds and methods of use | MEDIVATION TECHNOLOGIES LLC (US) | 2023-07-18 | — | — | US | disclosed |
| US-11702401-B2 | Compounds and methods of use | MEDIVATION TECHNOLOGIES LLC (US) | 2023-07-18 | — | — | US | disclosed |
| US-11702401-B2 | Compounds and methods of use | MEDIVATION TECHNOLOGIES LLC (US) | 2023-07-18 | — | — | US | disclosed |
| WO-1996013262-A1 | MUSCARINE ANTAGONISTS | MERCK & CO., INC. (US) | 1996-05-09 | — | — | WO | disclosed |
| JP-H05112559-A | 4-AMINO-5-PYRIMIDINECARBOXYLIC ACID DERIVATIVE | MORISHITA ROUSSEL KK | 1993-05-07 | — | — | JP | disclosed |
| US-5089490-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| US-4758556-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-19 | — | — | US | disclosed |
| US-4550168-A | Benzisoselenazolones and a process for the treatment of inflammatory diseases | A. NATTERMANN & CIE GMBH (DE) | 1985-10-29 | — | — | US | disclosed |
| EP-0100899-A2 | Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | A. Nattermann & Cie. GmbH (DE) | 1984-02-22 | — | — | EP | disclosed |
| US-4399131-A | Cephem derivatives | HOECHST AG (DE) | 1983-08-16 | — | — | US | disclosed |
| US-4278793-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702401-B2 | Compounds and methods of use | TGFB2, TGFB1, HDGF | NAPRT 2209/4885KDM4E 1713/4885KMT2A 2362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.